M
Mayara Lisboa Bastos
Researcher at Rio de Janeiro State University
Publications - 45
Citations - 2354
Mayara Lisboa Bastos is an academic researcher from Rio de Janeiro State University. The author has contributed to research in topics: Tuberculosis & Medicine. The author has an hindex of 15, co-authored 39 publications receiving 1503 citations. Previous affiliations of Mayara Lisboa Bastos include McGill University & McGill University Health Centre.
Papers
More filters
Journal ArticleDOI
Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis.
Mayara Lisboa Bastos,Mayara Lisboa Bastos,Gamuchirai Tavaziva,S.K. Abidi,Jonathon R. Campbell,Jonathon R. Campbell,Louis-Patrick Haraoui,James C. Johnston,Zhiyi Lan,Stephanie Law,Emily MacLean,Anete Trajman,Anete Trajman,Dick Menzies,Dick Menzies,Andrea Benedetti,Andrea Benedetti,Faiz Ahmad Khan,Faiz Ahmad Khan +18 more
TL;DR: Higher quality clinical studies assessing the diagnostic accuracy of serological tests for covid-19 are urgently needed, as available evidence does not support the continued use of existing point-of-care serological Tests for coronavirus disease-2019.
Journal ArticleDOI
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
Nafees Ahmad,Shama D. Ahuja,Onno W. Akkerman,Jan-Willem C. Alffenaar,Laura F Anderson,Parvaneh Baghaei,Didi Bang,Pennan M. Barry,Mayara Lisboa Bastos,Digamber Behera,Andrea Benedetti,Gregory P. Bisson,Martin J. Boeree,Maryline Bonnet,Sarah K. Brode,James C.M. Brust,Ying Cai,Eric Caumes,J. Peter Cegielski,Rosella Centis,Pei-Chun Chan,Edward D. Chan,Kwok-Chiu Chang,Macarthur Charles,Andra Cirule,Margareth Pretti Dalcolmo,Lia D'Ambrosio,Gerard de Vries,Keertan Dheda,Aliasgar Esmail,Jennifer Flood,Gregory J. Fox,Mathilde Fréchet-Jachym,Geisa Fregona,Regina Gayoso,Medea Gegia,Maria Tarcela Gler,Sue Gu,Lorenzo Guglielmetti,Timothy H. Holtz,Jennifer Hughes,Petros Isaakidis,Leah G. Jarlsberg,Russell R. Kempker,Salmaan Keshavjee,Faiz Ahmad Khan,Maia Kipiani,Serena P. Koenig,Won-Jung Koh,Afranio Lineu Kritski,Liga Kuksa,Charlotte Kvasnovsky,Nakwon Kwak,Zhiyi Lan,Christoph Lange,Rafael Laniado-Laborín,Myungsun Lee,Vaira Leimane,Chi-Chiu Leung,Eric Chung Ching Leung,Pei Zhi Li,Phil Lowenthal,Ethel Leonor Noia Maciel,Suzanne M. Marks,Sundari Mase,Lawrence Mbuagbaw,Giovanni Battista Migliori,Vladimir Milanov,Ann C. Miller,Carole D. Mitnick,Chawangwa Modongo,Erika Mohr,Ignacio Monedero,Payam Nahid,Norbert Ndjeka,Max R. O'Donnell,Nesri Padayatchi,Domingo Palmero,Jean W. Pape,Laura Jean Podewils,Ian R Reynolds,Vija Riekstina,Jérôme Robert,Maria I. Rodriguez,Barbara Seaworth,Kwonjune J. Seung,Kathryn Schnippel,Tae Sun Shim,Rupak Singla,Sarah Smith,Giovanni Sotgiu,Ganzaya Sukhbaatar,Payam Tabarsi,Simon Tiberi,Anete Trajman,Lisa Trieu,Zarir F Udwadia,Tjip S. van der Werf,Nicolas Veziris,Piret Viiklepp,Stalz Charles Vilbrun,Kathleen F. Walsh,Janice Westenhouse,Wing Wai Yew,Jae-Joon Yim,Nicola M. Zetola,Matteo Zignol,Dick Menzies +107 more
TL;DR: Treatment outcomes were significantly better with use of linezolid, later generation fluoroquinolones, bedaquiline, clofazimine, and carbapenems for treatment of multidrug-resistant tuberculosis, and the need for trials to ascertain the optimal combination and duration of these drugs is emphasised.
Journal ArticleDOI
Proportion of asymptomatic infection among COVID-19 positive persons and their transmission potential: A systematic review and meta-analysis.
Mercedes Yanes-Lane,Nicholas Winters,Federica Fregonese,Mayara Lisboa Bastos,Sara Perlman-Arrow,Jonathon R. Campbell,Jonathon R. Campbell,Dick Menzies +7 more
TL;DR: The proportion of asymptomatic infection among COVID-19 positive persons appears high and transmission potential seems substantial, and high quality studies in representative general population samples are required.
Journal ArticleDOI
The Sensitivity and Costs of Testing for SARS-CoV-2 Infection With Saliva Versus Nasopharyngeal Swabs : A Systematic Review and Meta-analysis.
TL;DR: In this paper, the difference in sensitivity for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detection between nasopharyngeal swabs and saliva was determined.
Journal ArticleDOI
Treatment Outcomes of Patients With Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis According to Drug Susceptibility Testing to First- and Second-line Drugs: An Individual Patient Data Meta-analysis
Mayara Lisboa Bastos,Hamidah Hussain,Karin Weyer,Lourdes García-García,Vaira Leimane,Chi Chiu Leung,Masahiro Narita,José Peña,Alfredo Ponce-de-León,Kwonjune J. Seung,Karen Shean,José Sifuentes-Osornio,Martie van der Walt,Tjip S. van der Werf,Wing Wai Yew,Dick Menzies,Dick Menzies +16 more
TL;DR: DST for ethambutol, pyrazinamide, and second-line tuberculosis drugs appears to provide clinically useful information to guide selection of treatment regimens for MDR and XDR tuberculosis.